Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...
Samsung Electronics Co., Ltd., a global leader in advanced memory technology, today announced that it has begun mass production of its industry-leading HBM4 and has shipped commercial products to ...
Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript February 10, 2026 Edwards Lifesciences Corporation misses on earnings expectations. Reported EPS is $0.58 EPS, expectations ...
Just after the close of regular trading, Edwards Lifesciences released fourth quarter and full year 2025 financial results. During today's call, management will discuss the results included in the ...
Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript February 4, 2026 Bio-Techne Corporation beats earnings ...
The newest, and most advanced cancer treatment in the world is now available to patients of Mary Mediatrix Medical Center in ...
The first facility to disperse sterile New World screwworm (NWS) flies from the United States in decades opened Monday in ...
DelveInsight's Invasive Fungal Infections Market Insights report includes a comprehensive understanding of current treatment ...
Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results